What Lucy Scientific Discovery, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Susin Livio | Director | Feb 13 | Other Transaction · J | +9,309 | $2.40 | +$22.3K | 134,809 |
| McElvany Christopher | President and CEO | Feb 13 | Derivative Conversion · C | +366,187 | $2.40 | +$879K | 366,187 |
| McElvany Christopher | President and CEO | Feb 13 | Other Transaction · J | +118,403 | $2.40 | +$284K | 118,403 |
| Kazeminy Assad J | Chief Scientific Officer | Feb 13 | Other Transaction · J | +85,000 | $2.40 | +$204K | 85,000 |
Loading...
